Risk factors for non-adherence to disease-modifying therapy in pediatric multiple sclerosis
- 1 February 2017
- journal article
- research article
- Published by SAGE Publications in Multiple Sclerosis Journal
- Vol. 24 (2) , 175-185
Abstract
Adherence to disease-modifying therapies (DMTs) in pediatric multiple sclerosis (MS) is not well understood. We examined the prevalence and risk factors for poor adherence in pediatric MS. This cross-sectional study recruited youth with MS from 12 North American pediatric MS clinics. In addition to pharmacy-refill data, patients and parents completed self-report measures of adherence and quality of life. Additionally, patients completed measures of self-efficacy and well-being. Factor analysis and linear regression methods were used. A total of 66 youth (mean age, 15.7 years) received MS DMTs (33% oral, 66% injectable). Estimates of poor adherence (i.e. missing >20% of doses) varied by source: pharmacy 7%, parent 14%, and patient 41%. Factor analysis yielded two composites: adherence summary and parental involvement in adherence. Regressions revealed that patients with better self-reported physical functioning were more adherent. Parents were more likely to be involved in adherence when their child had worse parent-reported PedsQL School Functioning and lower MS Self-Efficacy Control. Oral DMTs were associated with lesser parental involvement in adherence. Rates of non-adherence varied by information source. Better self-reported physical functioning was the strongest predictor of adherence. Parental involvement in adherence was associated with worse PedsQL School Functioning and lower MS Self-Efficacy-measured confidence in controlling MS.Keywords
Funding Information
- National Multiple Sclerosis Society (HC 0148)
This publication has 30 references indexed in Scilit:
- Use of an Online Community to Develop Patient-Reported Outcome Instruments: The Multiple Sclerosis Treatment Adherence Questionnaire (MS-TAQ)Journal of Medical Internet Research, 2011
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteriaAnnals of Neurology, 2011
- The Global Adherence Project (GAP): a multicenter observational study on adherence to disease‐modifying therapies in patients with relapsing‐remitting multiple sclerosisEuropean Journal of Neurology, 2010
- Adherence of Adolescents to Multiple Sclerosis Disease-Modifying TherapyPediatric Neurology, 2009
- Adherence to the immunomodulatory drugs for multiple sclerosis: contrasting factors affect stopping drug and missing dosesPharmacoepidemiology and Drug Safety, 2008
- Consensus definitions proposed for pediatric multiple sclerosis and related disordersNeurology, 2007
- Adherence to MedicationNew England Journal of Medicine, 2005
- Disease Steps in multiple sclerosisNeurology, 1995
- A power primer.Psychological Bulletin, 1992
- Happiness is everything, or is it? Explorations on the meaning of psychological well-being.Journal of Personality and Social Psychology, 1989